BG60937B2 - Тетрахидронафталени и съдържащи ги лекарствени средства - Google Patents

Тетрахидронафталени и съдържащи ги лекарствени средства Download PDF

Info

Publication number: BG60937B2
Authority: BG; Bulgaria
Prior art keywords: methylamino; tetrahydro; isopropyl; ethyl; benzimidazolyl
Prior art date: 1986-11-14

Application number

BG098469A

Other languages

Bulgarian (bg)

English (en)

Inventor

Quirico Branca

Roland Jaunin

Hans Maerki

Fraenzi Marti

Henri Ramuz

Original Assignee

F. Hoffmann - La Roche Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-14

Filing date

1994-02-14

Publication date

1996-06-28

1994-02-14 Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag

1996-06-28 Publication of BG60937B2 publication Critical patent/BG60937B2/bg

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Cardiology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Hydrogenated Pyridines (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Organic Insulating Materials (AREA)
Luminescent Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Steroid Compounds (AREA)

BG098469A 1986-11-14 1994-02-14 Тетрахидронафталени и съдържащи ги лекарствени средства BG60937B2 (bg)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH456586		1986-11-14

Publications (1)

Publication Number	Publication Date
BG60937B2 true BG60937B2 (bg)	1996-06-28

Family

ID=4278454

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG098469A BG60937B2 (bg)	1986-11-14	1994-02-14	Тетрахидронафталени и съдържащи ги лекарствени средства

Country Status (31)

Country	Link
US (1)	US4808605A (cs)
EP (1)	EP0268148B1 (cs)
JP (1)	JP2504490B2 (cs)
KR (1)	KR960004863B1 (cs)
CN (1)	CN1028991C (cs)
AT (1)	ATE70267T1 (cs)
AU (1)	AU600769B2 (cs)
BG (1)	BG60937B2 (cs)
CA (1)	CA1319144C (cs)
CS (2)	CS264350B2 (cs)
DE (2)	DE3775177D1 (cs)
DK (1)	DK171349B1 (cs)
DZ (1)	DZ1142A1 (cs)
ES (1)	ES2040234T3 (cs)
FI (1)	FI94414C (cs)
GR (1)	GR3004029T3 (cs)
HK (1)	HK110494A (cs)
HU (1)	HU215915B (cs)
IE (1)	IE60695B1 (cs)
IL (1)	IL84407A (cs)
LV (1)	LV5745B4 (cs)
MC (1)	MC1883A1 (cs)
MX (1)	MX173614B (cs)
NL (1)	NL970019I2 (cs)
NO (2)	NO172237C (cs)
NZ (1)	NZ222474A (cs)
PH (1)	PH23919A (cs)
PT (1)	PT86130B (cs)
SG (1)	SG114194G (cs)
ZA (1)	ZA878362B (cs)
ZW (1)	ZW20087A1 (cs)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2003283A1 (en) *	1988-12-05	1990-06-05	C. Anne Higley	Imidazoles for the treatment of atherosclerosis
CA2011461A1 (en) *	1989-03-20	1990-09-20	Urs Hengartner	Tetrahydronaphthalene derivatives
NL9001522A (nl) *	1990-07-04	1992-02-03	Schreiner Luchtvaart	Werkwijze voor het vervaardigen van een voorwerp bestaande uit een schuimkern en eventueel een of meer afdeklagen.
TW216770B (cs) *	1991-07-23	1993-12-01	Hoffmann La Roche
US5663166A (en) *	1991-10-18	1997-09-02	Genentech, Inc.	Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5250679A (en) *	1991-10-18	1993-10-05	Genentech, Inc.	Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
BR9509760A (pt) *	1994-11-23	1998-06-30	Neurogen Corp	Composto
DE69526073T2 (de)	1995-06-23	2002-08-22	Technische Universiteit Delft, Delft	Verfahren zur Herstellung eines schäumbaren Filmes
TR199700018A2 (tr) *	1996-01-31	1997-08-21	Hoffmann La Roche	Alfa,beta-doymamis organik karboksilik asitlerin imaline yönelik proses.
US5808088A (en) *	1997-04-30	1998-09-15	Roche Colorado Corporation	Preparation of mibefradil via an acetamide anion
US5811556A (en) *	1997-04-30	1998-09-22	Roche Colorado Corporation	Preparation of mibefradil via a naphthalenylacetic acid
US5811557A (en) *	1997-04-30	1998-09-22	Roche Colorado Corporation	Preparation of mibefradil via an acetonitrile anion
US6897305B2 (en) *	1998-06-08	2005-05-24	Theravance, Inc.	Calcium channel drugs and uses
US7101909B2 (en) *	1998-10-12	2006-09-05	Theravance, Inc.	Calcium channel drugs and uses
MXPA02000927A (es) *	1999-07-28	2003-07-14	Johnson & Johnson	Amina y derivados de amida como ligandos para el receptor del neuropeptido y y5 utiles en el tratamiento de obesidad y otros trastornos.
AU2001235364A1 (en) *	2000-02-25	2001-09-03	Novo-Nordisk A/S	Tetrahydronaphtalene derivatives and their use
AU2001235363A1 (en) *	2000-02-25	2001-09-03	Novo-Nordisk A/S	Mibefradil analogues and their use
ES2274854T3 (es) *	2000-05-08	2007-06-01	Pfizer Products Inc.	Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
FR2827862A1 (fr) *	2001-07-27	2003-01-31	Lipha	Derives imidazolylalkylarylalcanoiques et leurs applications en therapeutique
EP1438297A1 (en)	2001-10-10	2004-07-21	Aryx Therapeutics	Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
KR20030037081A (ko)	2001-11-02	2003-05-12	한국과학기술연구원	Ｔ 타입 칼슘채널을 조절하여 복통을 억제하는 방법
CN1681495B (zh)	2002-08-19	2010-05-12	辉瑞产品公司	用于治疗过度增生性疾病的组合物
US20050037063A1 (en) *	2003-07-21	2005-02-17	Bolton Anthony E.	Combined therapies
UA87986C2 (uk) *	2003-07-28	2009-09-10	Янссен Фармацевтика Н.В.	Бензімідазольні, бензтіазольні та бензоксазольні похідні і їх застосування як lta4h модуляторів
CA2574958A1 (en) *	2004-07-26	2006-02-09	Cotherix, Inc.	Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
EP2351569B1 (en)	2005-10-26	2012-08-22	Asahi Kasei Pharma Corporation	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
JP2009513660A (ja) *	2005-10-26	2009-04-02	旭化成ファーマ株式会社	肺動脈性高血圧の治療用併用療法におけるファスジル
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
US8404896B2 (en)	2006-12-01	2013-03-26	Bristol-Myers Squibb Company	N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
TW200906396A (en) *	2007-02-14	2009-02-16	Janssen Pharmaceutica Nv	LTA4H modulators and uses thereof
AR066148A1 (es) *	2007-04-27	2009-07-29	Actelion Pharmaceuticals Ltd	Derivados puenteados de ciclohexeno bloqueadores del canal de calcio
EP2336125B1 (en) *	2008-04-11	2013-01-09	Janssen Pharmaceutica N.V.	Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
KR101364909B1 (ko) *	2008-04-25	2014-02-21	액테리온 파마슈티칼 리미티드	칼슘 채널 차단제로서의 벤지미다졸 유도체
JP2012506415A (ja)	2008-10-22	2012-03-15	アクテリオンファーマシューティカルズリミテッド	架橋テトラヒドロナフタレン誘導体
WO2010046729A2 (en) *	2008-10-23	2010-04-29	Actelion Pharmaceuticals Ltd	Tetrahydronaphthalene compounds
US20120172429A1 (en)	2009-07-10	2012-07-05	Woolf Clifford J	Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
EP2542534A1 (en)	2010-03-02	2013-01-09	Concert Pharmaceuticals Inc.	Deuterated tetrahydronaphthalene derivatives
US8575361B2 (en)	2010-03-02	2013-11-05	Concert Pharmaceuticals Inc.	Tetrahydronaphthalene derivatives
WO2012037665A1 (en)	2010-09-24	2012-03-29	Oral Delivery Technology Ltd.	Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
BR112015026513A2 (pt)	2013-04-17	2017-07-25	Pfizer	derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
WO2017070680A1 (en)	2015-10-22	2017-04-27	Cavion Llc	Methods for treating angelman syndrome and related disorders
CN110545806A (zh) *	2017-02-15	2019-12-06	卡维昂公司	钙通道抑制剂
US11324733B2 (en)	2017-04-26	2022-05-10	Cavion, Inc.	Methods for improving memory and cognition and for treating memory and cognitive disorders
TWI879741B (zh)	2018-10-03	2025-04-11	美商卡凡恩公司	以(r)-2-(4-異丙基苯基)-n-(1-(5-(2,2,2-三氟乙氧基)吡啶-2-基)乙基)乙醯胺治療自發性震顫
RS66416B1 (sr)	2019-01-18	2025-02-28	Astrazeneca Ab	6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene
CN115850119A (zh) *	2022-11-26	2023-03-28	南昌大学	一种2-氯芳香胺类化合物的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3914216A (en) *	1962-12-18	1975-10-21	Boehringer Sohn Ingelheim	1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
BE793460A (fr) *	1971-12-29	1973-06-28	Boehringer Sohn Ingelheim	Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h
NZ213651A (en) *	1984-10-11	1989-07-27	Hoffmann La Roche	Tetrahydronapthalene derivatives and medicaments

1987
- 1987-10-26 CA CA000550190A patent/CA1319144C/en not_active Expired - Fee Related
- 1987-10-26 DK DK559987A patent/DK171349B1/da not_active IP Right Cessation
- 1987-11-03 ZW ZW200/87A patent/ZW20087A1/xx unknown
- 1987-11-03 CS CS877874A patent/CS264350B2/cs not_active IP Right Cessation
- 1987-11-04 EP EP87116251A patent/EP0268148B1/de not_active Expired - Lifetime
- 1987-11-04 AT AT87116251T patent/ATE70267T1/de active
- 1987-11-04 ES ES198787116251T patent/ES2040234T3/es not_active Expired - Lifetime
- 1987-11-04 DE DE8787116251T patent/DE3775177D1/de not_active Expired - Lifetime
- 1987-11-04 DE DE1997175076 patent/DE19775076I2/de active Active
- 1987-11-06 NZ NZ222474A patent/NZ222474A/xx unknown
- 1987-11-06 ZA ZA878362A patent/ZA878362B/xx unknown
- 1987-11-09 AU AU80909/87A patent/AU600769B2/en not_active Ceased
- 1987-11-09 IL IL84407A patent/IL84407A/xx unknown
- 1987-11-10 US US07/119,114 patent/US4808605A/en not_active Expired - Lifetime
- 1987-11-10 JP JP62282287A patent/JP2504490B2/ja not_active Expired - Lifetime
- 1987-11-11 HU HU875011A patent/HU215915B/hu not_active IP Right Cessation
- 1987-11-11 PH PH36056A patent/PH23919A/en unknown
- 1987-11-11 DZ DZ870191A patent/DZ1142A1/fr active
- 1987-11-12 MX MX009271A patent/MX173614B/es unknown
- 1987-11-12 MC MC871928A patent/MC1883A1/fr unknown
- 1987-11-13 KR KR87012777A patent/KR960004863B1/ko not_active Expired - Fee Related
- 1987-11-13 IE IE307087A patent/IE60695B1/en not_active IP Right Cessation
- 1987-11-13 PT PT86130A patent/PT86130B/pt not_active IP Right Cessation
- 1987-11-13 NO NO874757A patent/NO172237C/no not_active IP Right Cessation
- 1987-11-13 FI FI875024A patent/FI94414C/fi not_active IP Right Cessation
- 1987-11-13 CN CN87107875A patent/CN1028991C/zh not_active Expired - Fee Related
1991
- 1991-12-20 CS CS913948A patent/CS394891A3/cs unknown
1992
- 1992-03-11 GR GR920400420T patent/GR3004029T3/el unknown
1994
- 1994-02-14 BG BG098469A patent/BG60937B2/bg unknown
- 1994-08-13 SG SG114194A patent/SG114194G/en unknown
- 1994-10-12 HK HK110494A patent/HK110494A/xx not_active IP Right Cessation
1996
- 1996-05-24 LV LV960155A patent/LV5745B4/xx unknown
1997
- 1997-05-27 NL NL970019C patent/NL970019I2/nl unknown
1998
- 1998-01-09 NO NO1998001C patent/NO1998001I1/no unknown

Also Published As

Publication number	Publication date
HU215915B (hu)	1999-03-29
FI875024A7 (fi)	1988-05-15
IE60695B1 (en)	1994-08-10
AU600769B2 (en)	1990-08-23
DK559987D0 (da)	1987-10-26
FI94414C (fi)	1995-09-11
NO1998001I1 (no)	1998-01-09
NL970019I1 (nl)	1997-08-01
US4808605A (en)	1989-02-28
NO874757D0 (no)	1987-11-13
DE3775177D1 (de)	1992-01-23
CA1319144C (en)	1993-06-15
CS264350B2 (en)	1989-07-12
NZ222474A (en)	1990-02-26
ZA878362B (en)	1988-05-16
NO874757L (no)	1988-05-16
MX173614B (es)	1994-03-18
NO172237C (no)	1993-06-23
KR880006163A (ko)	1988-07-21
SG114194G (en)	1994-11-25
HK110494A (en)	1994-10-21
CN87107875A (zh)	1988-05-25
IE873070L (en)	1988-05-14
ZW20087A1 (en)	1988-07-20
PT86130A (en)	1987-12-01
PT86130B (pt)	1990-11-20
CS787487A2 (en)	1988-11-15
CN1028991C (zh)	1995-06-21
FI875024A0 (fi)	1987-11-13
EP0268148B1 (de)	1991-12-11
GR3004029T3 (cs)	1993-03-31
MC1883A1 (fr)	1989-01-24
LV5745A4 (lv)	1996-10-20
JP2504490B2 (ja)	1996-06-05
PH23919A (en)	1990-01-23
IL84407A0 (en)	1988-04-29
CS394891A3 (en)	1992-06-17
MX9271A (es)	1993-09-01
DZ1142A1 (fr)	2004-09-13
DK171349B1 (da)	1996-09-16
LV5745B4 (lv)	1996-12-20
ES2040234T3 (es)	1993-10-16
HUT60251A (en)	1992-08-28
KR960004863B1 (en)	1996-04-16
NO172237B (no)	1993-03-15
AU8090987A (en)	1988-05-19
EP0268148A1 (de)	1988-05-25
NL970019I2 (nl)	1997-11-03
JPS63139171A (ja)	1988-06-10
FI94414B (fi)	1995-05-31
IL84407A (en)	1991-09-16
DE19775076I2 (de)	2001-08-09
DK559987A (da)	1988-05-15
ATE70267T1 (de)	1991-12-15

Publication	Publication Date	Title
BG60937B2 (bg)	1996-06-28	Тетрахидронафталени и съдържащи ги лекарствени средства
FI114983B (fi)	2005-02-15	Menetelmä bentsimidatsoli-7-karboksylaatin C-tyyppiä olevan kiteen valmistamiseksi
US5276049A (en)	1994-01-04	Cyclic urea derivatives, pharmaceutical compositions containing these compounds and methods of using the same
US6346532B1 (en)	2002-02-12	Amide derivatives or salts thereof
EP3715341A1 (en)	2020-09-30	Halo-allylamine ssao/vap-1 inhibitor and use thereof
CZ82098A3 (cs)	1998-08-12	Selektivní ß3 adrenergičtí agonisté
JP2005518371A (ja)	2005-06-23	バニロイド受容体リガンド及び治療に於けるこれらの使用
HUP0200710A2 (en)	2002-06-29	Benzimidazoles, production thereof and use thereof as medicaments
DE4429079A1 (de)	1996-02-22	Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO1999026932A1 (en)	1999-06-03	By amidino group substituted heterocyclic derivatives and their use as anticoagulants
EP0268229B1 (en)	1992-07-08	Imidazolidinone compounds, processes for preparation thereof, compositions comprising such compounds, and the use of such compounds for the manufacture of medicaments having therapeutic value
KR101087966B1 (ko)	2011-12-01	치환된 티오펜, 이의 제조방법, 및 이를 포함하는 약제학적 조성물
SK5712003A3 (en)	2003-11-04	Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
US7008955B2 (en)	2006-03-07	(2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists
KR19990022318A (ko)	1999-03-25	평활근 세포 증식 억제제로서의 2-치환된 벤즈이미다졸 유도체
FR2695388A1 (fr)	1994-03-11	Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation.
US20240409532A1 (en)	2024-12-12	Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
JP2024511101A (ja)	2024-03-12	新規カリウムチャネル阻害剤
HK40028252A (en)	2021-01-29	Halo-allylamine ssao/vap-1 inhibitor and use thereof
SI8810229A8 (en)	1996-12-31	Process for preparation of tetrahydronaphtalene derivatives
JPS6377874A (ja)	1988-04-08	キナゾリン誘導体を含有する強心剤
CZ289405B6 (cs)	2002-01-16	Benzimidazolové deriváty, způsob jejich výroby, farmaceutický prostředek je obsahující a intermediáty pro jejich výrobu
JPH06228100A (ja)	1994-08-16	光学活性アミノピリジン誘導体およびその用途
HK1000803B (en)	1998-05-01	Benzimidazole derivatives, their production and use
FR2489822A1 (fr)	1982-03-12	Derives de l'imidazole, leur preparation et leurs utilisations therapeutiques